Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-05-25

FDA Approved: GLIPIZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals, Inc.'s supplemental application for glipizide (generic).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glipizide (Glipizide)

Snippet

SUPPL AP for GLIPIZIDE (GLIPIZIDE)